NCT03728946

Brief Summary

The purpose of this study is to examine the difference in perioperative pain after shoulder surgery with a standard bupivacaine nerve block compared to liposomal bupivacaine enhanced nerve block alone in TSA and ARCR. Data will be compared using VAS scores and opiate consumption between the two groups. The hypothesis of this study is that an interscalene nerve block with liposomal bupivacaine will decrease both postoperative VAS pain scores and total narcotic consumption when compared to a standard bupivacaine interscalene nerve block alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 2, 2018

Completed
19 days until next milestone

Study Start

First participant enrolled

November 21, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

March 24, 2020

Status Verified

March 1, 2020

Enrollment Period

1.3 years

First QC Date

October 31, 2018

Last Update Submit

March 22, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Opiate Consumption

    Total amount of narcotics consumed during the postoperative period, measured in morphine equivalents (OME)

    Post-operative days 1-14

Secondary Outcomes (2)

  • VAS Pain Scores

    Post operative days 1-14

  • Likert Pain Satisfaction Rating

    Post operative days 1-14

Study Arms (2)

Liposomal Bupivacaine Interscalene Block

EXPERIMENTAL

Liposomal bupivacaine anesthetic will be administered as an interscalene block during rotator cuff repair surgery and total shoulder arthroplasty.

Drug: Liposomal Bupivacaine

Bupivacaine Interscalene Block

NO INTERVENTION

Bupivacaine anesthetic will be administered as an interscalene block during rotator cuff repair surgery and total shoulder arthroplasty.

Interventions

Addition of 15mL of liposomal bupivacaine to 15mL of standard nerve block anesthetic solution containing 0.5% bupivacaine and 4mg of decadron

Also known as: EXPAREL
Liposomal Bupivacaine Interscalene Block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 undergoing rotator cuff repair or total shoulder arthroplasty

You may not qualify if:

  • Pregnant
  • Documented drug of alcohol abuse
  • Active narcotic use prior to surgery
  • Neurological deficit
  • Allergy to amide anesthetics
  • Not cleared by primary care physician
  • Hydrocodone or oxycodone intolerance
  • Enrollment in another clinical trial or past cognitive or mental health status that interferes with study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Greenwich Hospital

Greenwich, Connecticut, 06830, United States

Location

Orthopaedic & Neurosurgery Specialists

Greenwich, Connecticut, 06831, United States

Location

Stamford Ambulatory Surgical Center

Stamford, Connecticut, 06902, United States

Location

Atlantis Orthopaedics

Atlantis, Florida, 06831, United States

Location

Atlantis Orthopaedics

Palm Beach Gardens, Florida, 33410, United States

Location

Southern Oregon Orthopedics, Inc.

Medford, Oregon, 97504, United States

Location

Related Publications (6)

  • Kumar K, Gulotta LV, Dines JS, Allen AA, Cheng J, Fields KG, YaDeau JT, Wu CL. Unused Opioid Pills After Outpatient Shoulder Surgeries Given Current Perioperative Prescribing Habits. Am J Sports Med. 2017 Mar;45(3):636-641. doi: 10.1177/0363546517693665. Epub 2017 Feb 9.

    PMID: 28182507BACKGROUND
  • Lee CY, Robinson DA, Johnson CA Jr, Zhang Y, Wong J, Joshi DJ, Wu TT, Knight PA. A Randomized Controlled Trial of Liposomal Bupivacaine Parasternal Intercostal Block for Sternotomy. Ann Thorac Surg. 2019 Jan;107(1):128-134. doi: 10.1016/j.athoracsur.2018.06.081. Epub 2018 Aug 28.

    PMID: 30170012BACKGROUND
  • Pedoto A, Amar D. Liposomal Bupivacaine for Intercostal Nerve Block: Pricey or Priceless? Semin Thorac Cardiovasc Surg. 2017 Winter;29(4):538-539. doi: 10.1053/j.semtcvs.2017.08.016. Epub 2017 Aug 30. No abstract available.

    PMID: 28967536BACKGROUND
  • Rice DC, Cata JP, Mena GE, Rodriguez-Restrepo A, Correa AM, Mehran RJ. Posterior Intercostal Nerve Block With Liposomal Bupivacaine: An Alternative to Thoracic Epidural Analgesia. Ann Thorac Surg. 2015 Jun;99(6):1953-60. doi: 10.1016/j.athoracsur.2015.02.074. Epub 2015 Apr 23.

    PMID: 25912739BACKGROUND
  • Surdam JW, Licini DJ, Baynes NT, Arce BR. The use of exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients. J Arthroplasty. 2015 Feb;30(2):325-9. doi: 10.1016/j.arth.2014.09.004. Epub 2014 Sep 16.

    PMID: 25282071BACKGROUND
  • Vandepitte C, Kuroda M, Witvrouw R, Anne L, Bellemans J, Corten K, Vanelderen P, Mesotten D, Leunen I, Heylen M, Van Boxstael S, Golebiewski M, Van de Velde M, Knezevic NN, Hadzic A. Addition of Liposome Bupivacaine to Bupivacaine HCl Versus Bupivacaine HCl Alone for Interscalene Brachial Plexus Block in Patients Having Major Shoulder Surgery. Reg Anesth Pain Med. 2017 May/Jun;42(3):334-341. doi: 10.1097/AAP.0000000000000560.

    PMID: 28157791BACKGROUND

MeSH Terms

Conditions

Rotator Cuff InjuriesPain, Postoperative

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon InjuriesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 31, 2018

First Posted

November 2, 2018

Study Start

November 21, 2018

Primary Completion

March 1, 2020

Study Completion

March 1, 2020

Last Updated

March 24, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations